ICD-10-CM Billable Code

M08.40

Pauciarticular juvenile rheumatoid arthritis, unspecified site

Clinical Classification Guidelines

Medical Intelligence & Overview

Pauciarticular juvenile rheumatoid arthritis (JRA), also known as oligoarthritis, is a type of juvenile arthritis that affects a limited number of joints, typically four or fewer. Classified under ICD-10 code M08.40, this condition predominantly impacts children and adolescents. It is characterized by inflammation that can cause pain, swelling, and stiffness in affected joints, which may lead to long-term joint damage if not properly managed. The term 'pauciarticular' indicates the limited involvement of joints, differentiating it from other forms of juvenile arthritis that might involve many joints or internal organs.

Causes & Symptoms

Clinical Causes: Genetic predisposition: Certain genes may increase susceptibility. Immune system dysfunction: The immune system mistakenly attacks joint tissues. Environmental factors: Infections or other environmental triggers may play a role, although they are not definitively established.

Key Symptoms: Joint pain and tenderness, especially in the knees, ankles, or wrists. Swelling around the affected joints. Stiffness, particularly in the mornings or after periods of inactivity. Limited range of motion in involved joints. Possible asymmetry, affecting only one side of the body. Light fever or rash in some cases. Eye inflammation (uveitis), which may not have immediate symptoms but can pose risks if untreated.

Diagnostic & Treatment

Diagnosis Path: Diagnosis involves a combination of clinical examination, medical history, and laboratory testing. Key components include: - Physical assessment to check for joint swelling, warmth, and range of motion. - Blood tests such as inflammatory markers (ESR, CRP) to detect systemic inflammation. - Imaging studies like X-rays or ultrasounds to assess joint damage or inflammation. - Eye examinations to identify potential uveitis. Since there is no single definitive test, diagnosis is based on criteria including the number and pattern of joints involved, symptom duration, and exclusion of other causes of arthritis.

Treatment Protocols: While this overview does not replace professional medical advice, common approaches to managing pauciarticular juvenile rheumatoid arthritis typically include: - Nonsteroidal anti-inflammatory drugs (NSAIDs) to reduce pain and inflammation. - Disease-modifying anti-rheumatic drugs (DMARDs) like methotrexate in more persistent or severe cases. - Corticosteroids for short-term control of inflammation. - Regular physical therapy to maintain joint function and prevent stiffness. - Monitoring and managing eye health to prevent complications such as uveitis. - Supportive measures including eye protection, appropriate activity levels, and ergonomic adjustments. Early diagnosis and consistent management are key to reducing joint damage and improving long-term function.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is M08.40 a billable ICD-10 code?
Yes, M08.40 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report M08.40?
Clinical documentation must specify the nature of Pauciarticular juvenile rheumatoid arthritis, unspecified site and any associated comorbidities for accurate reporting.

Cite this Clinical Reference